Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.

Folia histochemica et cytobiologica - 1 Jan 2009

Dobrzycka Bozena, Terlikowski Sławomir J, Mazurek Andrzej, Kowalczuk Oksana, Niklińska Wiesława, Chyczewski Lech, Kulikowski Marek

Abstract excerpt

The aim of this study was to examine the prevalence and clinicopathological significance of KRAS point mutation in endometrial hyperplasia and carcinoma. We analysed KRAS in 11 cases of complex atypical hyperplasia and in 49 endometrial carcinomas using polymerase chain reaction associated with restriction fragment length polymorphism (PCR-RFPL). Point mutations at codon 12 of KRAS oncogene were identified in 7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endometrial Hyperplasia

Share to Endometrial Neoplasms

Share to Oncogenes

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 19419940
DOI: 10.2478/v10042-009-0014-2

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.PMID 19419940Read ↗

Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.Semantic proximity Read ↗

Molecular profiles of benign and (pre)malignant endometrial lesions.Semantic proximity Read ↗

KRAS Mutations in Mucinous Lesions of the Uterus.Semantic proximity Read ↗

Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium.Semantic proximity Read ↗

K-ras activation in premalignant and malignant epithelial lesions of the human uterus.Semantic proximity Read ↗

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.Semantic proximity Read ↗

Mutations of RAS genes in endometrial polyps.Semantic proximity Read ↗

BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.Semantic proximity Read ↗

Analysis of oncogene alterations in human endometrial carcinoma: prevalence of ras mutations.Semantic proximity Read ↗

The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancerSemantic proximity Read ↗

K- ras gene point mutations in human endometrial carcinomas: correlation with clinicopathological features and patients' outcomeSemantic proximity Read ↗

Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.